Sarah DevaneyThe University of Manchester · School of Law
Sarah Devaney
LL.B, MA, PhD
About
29
Publications
1,891
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
135
Citations
Citations since 2017
Publications
Publications (29)
In recent years, researchers have begun to explore the use of Distributed Ledger Technologies (DLT), also known as blockchain, in health data sharing contexts. However, there is a significant lack of research that examines public attitudes towards the use of this technology. In this paper, we begin to address this issue and present results from a s...
In recent years we have seen the adoption of distributed ledger technology (DLT), originally the mechanism underpinning the operation of the Bitcoin crypto currency, across a wider range of technology sectors including healthcare. DLT allows for the design of informatics systems with the properties of immutability, security, and decentralization. O...
Data providers holding sensitive medical data often need to exchange data pertaining to patients for whom they hold particular data. This involves requesting information from other providers to augment the data they hold. However, revealing the superset of identifiers for which a provider requires information can, in itself, leak sensitive private...
In the United Kingdom, the question of how much information is required to be given to patients about the benefits and risks of proposed treatment remains extant. Issues about whether healthcare resources can accommodate extended shared decision-making processes are yet to be resolved. COVID-19 has now stepped into this arena of uncertainty, adding...
This article argues that the use of reputation-affecting regulatory measures can enhance efforts to regulate research in the biotechnology sector at an international level by increasing actors' inclination to comply and by encouraging the culture of the sector to become one in which ‘science solidarity’ is embedded. It characterises the sector as h...
The UK Supreme Court held in Montgomery v Lanarkshire HB (2015) that practitioners must take reasonable care to ensure patients are aware of any material risks involved in treatment. We reviewed all court decisions since Montgomery which deal with the case, to establish how this judgment is being interpreted by the courts and the implications of th...
This article critically considers the question of whether an increase in legal recognition of patient autonomy culminating in the decision of the Supreme Court in Montgomery v Lanarkshire Health Board in 2015 has led to the death of deference to doctors, not only within the courts and healthcare regulatory arenas in England and Wales but also in th...
The criminal law looks set to play a larger role in regulating healthcare. Until recently, health professionals only faced the prospect of criminal liability if it could be proved that their gross negligence resulted in the death of a patient. In such a case, the professional could face a charge of gross negligence manslaughter (GNM). Prosecutions...
Hopes are high that stem cell (SC) research will lead to treatments and cures for some of the most serious diseases affecting humankind today. SC science has been used in a treatment setting in the replacement of patients’ windpipes and in restoring sight to patients who were blind in one eye and in future it is hoped that when the body is injured...
The Nuffield Council on Bioethics' 2011 report, Human Bodies: Donation for Medicine and Research, proposes a system for examining the ethical implications of different types of incentives for the provision of human tissue for use in medicine and research. The cornerstone of this system is the principle of altruism which, the Council recommends, sho...
The Court of Appeal of England and Wales ruled in the case of Yearworth and Others v North Bristol NHS Trust that sperm stored by six men for their future reproductive use was the property of its progenitors. This chapter explores whether the status of property which was bestowed upon sperm intended for reproductive use can equally be applied to hu...
The application of Principles-Based Regulation (PBR) to stem cell (SC) research has been adopted with little apparent controversy. However, this was the form of regulation being used in the financial sector leading up to the current financial crisis, giving rise to questions about its ability to regulate fast-moving areas effectively. This article...
Stem cell (SC) science is part of the growing trend of emerging technologies which depend for their success on the physical contribution of human raw materials—that is, tissues such as ova and embryos—by willing providers. These vital contributors, without whom many SC research projects would simply fail to be undertaken, are however excluded by UK...
This report was commissioned by the No-Fault Compensation Review Group in Scotland. It provides an up-to-date analysis of existing no-fault schemes in New Zealand, Sweden, Denmark, Norway, and Finland, as well as limited schemes which operate in Virginia and Florida in the United States. Drawing on such analysis, the report considers a number of sp...
The Human Fertilization and Embryology Authority policy on permitting ova provision for research purposes breaches good regulatory practice in being inconsistent, unaccountable and untargeted. This article will illustrate how these breaches have resulted in a policy which is unfair to ova providers who wish to contribute to stem cell research and u...
This article examines the government's reform of the current system of clinical negligence litigation in England, focusing on an analysis of the redress scheme for low value claims to be established under the NHS Redress Act 2006. The Act establishes a scheme to provide a package of redress to patients in circumstances where they have suffered harm...
A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK's attempts to become a global leader in this field.
Advances in scientific knowledge through the pursuit of stem cell research could provide great benefits to society in the form of treatments for illnesses. Such research should be conducted in compliance with international ethical standards agreed upon by those working in the arena.
Projects
Project (1)
This ESRC/Food Standards Agency funded research has three distinct but integrated research streams to answer the question: How does the nature, functioning and regulation of a food supply network affect the risk of food fraud by adulteration? This research question is allied to one anticipated integrative output: a predictive, transposable dynamic computational model that will outline nodes in a food supply network vulnerable to criminal acts of adulteration.
